STAASTAAR Surgical Company

NAS · US · Healthcare · Medical Instruments & Supplies · staar.com

23.14USD-6.16%Mkt Cap: 1.16B $P/E: 289.253d ago

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offe…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc.

$135.72BUSDP/E 43.4

EssilorLuxottica Societe anonyme

$81.53BUSDP/E 30.5

BDX

Becton, Dickinson and Company

$52.30BUSDP/E 33.2

MDLN

Medline Inc. Class A Common Stock

West Pharmaceutical Services, Inc.

$24.85BUSDP/E 45.2

DIM

Sartorius Stedim Biotech

$20.46BUSDP/E 64.5

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$14.73BUSDP/E 69.1

SOLV

Solventum Corporation Common Stock

$15.25BUSDP/E 10.9

COO

The Cooper Companies, Inc.

$14.87BUSDP/E 64.6

BAX

Baxter International Inc.

$13.62BUSD

ALGN

Align Technology, Inc.

Key Statistics

Company

Market Cap1.16B $

Enterprise Value1.01B $

Revenue (TTM)339.59M $

Gross Profit182.42M $

Net Income (TTM)-80.45M $

Revenue/Share6.804 USD

Last Price23.14 USD

Fiscal Year EndJan 2026

MR QuarterJul 2026

Employees921

CountryUS

SectorHealthcare

IndustryMedical Instruments & Supplies

ISINUS8523123052

Valuation

P/E (Trailing)289.25

P/E (Forward)22.53

PEG0.76

EV/EBITDA20.32

EV/Revenue2.98

P/S3.41

P/B3.26

EPS (TTM)0.07

EPS (Forward)1.02

52W Range

15.5937% of range35.87

52W High35.87 USD

52W Low15.59 USD

Profitability

Gross Margin76.19%

Oper. Margin10.89%

EBITDA Margin14.65%

Profit Margin-33.60%

ROE-23.37%

ROA-17.81%

Growth

Revenue Growth111.00%

Earnings Growth—

Cash Flow & Leverage

Operating CF-34.23M $

CapEx (TTM)5.82M $

FCF Margin4.52%

FCF Yield1.32%

Net Debt-145.55M $

Net Debt/EBITDA-2.92

Balance Sheet

Debt/Equity0.11

Current Ratio4.67

Quick Ratio3.86

Book Value/Sh7.078 USD

Cash/Share3.619 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:2

Split DateMay 18, 1992

Analyst Consensus

Rating2.7 (Hold)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)27.90 USD

Upside (mean)+20.6%

Target Range19.00 USD – 37.00 USD

$19.00+20.6% to mean$37.00

# Analysts10

Ownership

Shares Out.50.14M

Float26.14M

Insiders0.85%

Institutions111.61%

Short Interest

Short Ratio5.3d

Short % Float21.01%

Short % Out.9.99%

Shares Short4.98M

Short (prev mo.)5.28M

Technical

SMA 5026.41 (-12.4%)

SMA 20024.21 (-4.4%)

Beta1.23

S&P 52W Chg18.16%

Avg Vol (30d)990.66K

Avg Vol (10d)1.09M

Technical Indicators

RSI (14)40.4

MACD-0.5108

MACD Signal-0.6399

MACD Hist.+0.1290

BB Upper26.05 USD

BB Middle24.16 USD

BB Lower22.26 USD

BB Width15.71%

ATR (14)1.488 USD

Vol Ratio (20d)0.72x